世界のインターベンショナル心臓病装置市場(~2025年):種類別(ステント、構造的心臓、カテーテル、プラーク修正(アテレクトミー)、血行動態変化(塞栓保護、完全閉塞)、ガイドワイヤー、イントロデューサーシース、IVUS)

◆英語タイトル:Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2025
◆商品コード:MD-3456
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年1月28日
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は世界のインターベンショナル心臓病装置市場規模が2020年212億ドルから2025年138億ドルまで、年平均8.9%成長すると予測しています。本調査レポートでは、インターベンショナル心臓病装置の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別(ステント、構造的心臓装置、カテーテル、血管形成バルーン、プラーク改質装置、血行動態変化装置、その他)分析、地域別分析、競争状況、企業情報を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・インターベンショナル心臓病装置の世界市場規模:種類別(ステント、構造的心臓装置、カテーテル、血管形成バルーン、プラーク改質装置、血行動態変化装置、その他)
・インターベンショナル心臓病装置の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global interventional cardiology devices marketsize is projected to reach USD 21.2billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9% during the forecast period.”
The rapid growth in the geriatric population and the associated increase in the prevalence of interventional cardiology diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries are driving the growth of the interventional cardiology devices.

“Thrombectomy devicesaccountedfor the larger share of theplaque modification devices market in 2019.”
Based on type, the plaque modification devices market is segmented into atherectomy and thrombectomy. In 2019, the thrombectomy devices segment accounted for the larger market share, mainly due to the increasing incidence of blood clots andaortic embolisms across the globe.

“Embolic protection devicesaccounted for the largest share of thehemodynamic flow altration devices market in 2019.”
Based on type, the hemodynamic flow alteration devices market is segmented into embolic protection devices and chronic total occlusion devices. In 2019, the embolic protection devices segment accounted for the larger share of the hemodynamic flow alteration devices market. This can be attributed to the advantages of EPDs over CTO devices, such as the ability to capture embolic debris without interrupting continuous blood flow.

“Asia Pacific estimated to register the highest CAGRduring the forecast period.”
In this report, the interventional cardiology devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific isprojected to grow at the highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of a large pool of aging population, increasing prevalence of diabetes, and rising focus of key players in this region.

Breakdown of primary supply-side interviews, by company type, designation, and region:
• By Company Type: Tier 1 (70%) , Tier 2 (20%), and Tier 3 (10%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), AsiaPacific (25%), and Rest of the World(16%)

List of players profiled in this report:
1. Medtronic (Ireland)
2. Boston Scientific Corporation (US)
3. B. Braun Melsungen AG(Germany)
4. Abbott (US)
5. Cardinal Health (US)
6. Edward Lifesciences Corporation(US)
7. Penumbra, Inc. (US)
8. Terumo Corporation (Japan)
9. Alvimedica (Turkey)
10. ENDOCOR GmbH (Germany)
11. Biosensor International (Singapore)
12. Koninklijke Philips N.V. (Netherlands)
13. AMG International GmbH (Germany)
14. iVascular (Spain)
15. SMT (India)
16. Meril Life Sciences Pvt Ltd. (India)
17. Medinol (Israel)
18. InSitu Technologies, Inc. (US)
19. Andramed GmbH (Germany)
20. Cardionovum GmbH (Germany)
21. Wellinq (Netherlands)
22. SCITECH (Brazil)
23. Comed B.V (Netherlands)
24. BALTON Sp. z o.o (Poland)
25. Rontis (Switzerland)
26. STENTYS S.A. (France)

Research Coverage
This report studies the interventional cardiology devices market based on product and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarketswith respect to their growth trends, prospects, and contributions to the total interventional cardiology devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the interventional cardiology devices offered by the top 10 players in the market. The report analyzes the interventional cardiology devices market by product and region
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various interventional cardiology devices across key geographic regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional cardiology devices market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the interventional cardiology devices market

【レポートの目次】

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION 28
1.3.2 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 29
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 30
1.8 LIMITATIONS OF THE CURRENT EDITION 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Secondary sources 32
2.1.2 PRIMARY DATA 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 33
2.2 MARKET SIZE ESTIMATION 33
2.2.1 BOTTOM-UP APPROACH 33
2.2.1.1 Bottom-up approach for the interventional cardiology devices market 34
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 34
2.2.2 TOP-DOWN APPROACH 34
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 34
2.2.3 GROWTH FORECAST 34
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 35
FIGURE 6 DATA TRIANGULATION METHODOLOGY 35
2.4 ASSUMPTIONS FOR THE STUDY 36
3 EXECUTIVE SUMMARY 37
FIGURE 7 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 37
FIGURE 8 STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 38
FIGURE 9 CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 38
FIGURE 10 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 39
FIGURE 11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 39
FIGURE 12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 40
FIGURE 13 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 40
FIGURE 14 GEOGRAPHIC SNAPSHOT OF THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET 41
4 PREMIUM INSIGHTS 42
4.1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET OVERVIEW 42
FIGURE 15 INCREASING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE GROWTH IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET 42
4.2 ANGIOPLASTY STENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 43
FIGURE 16 DRUG-ELUTING STENTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019 43
4.3 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY CATHETER TYPE AND COUNTRY 44
FIGURE 17 THE US IS EXPECTED TO DOMINATE THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET IN 2020 44
4.4 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: GEOGRAPHIC SNAPSHOT 45
FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 19 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 47
5.2.1.1 Growing prevalence of coronary artery disease 47
FIGURE 20 GLOBAL INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2030 VS. 2045 47
5.2.1.2 Rising tobacco consumption and increasing incidence of obesity 48
5.2.1.3 Favorable reimbursements for interventional cardiology procedures 48
TABLE 1 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES IN THE US 48
5.2.2 RESTRAINTS 49
5.2.2.1 Availability of alternative treatments 49
5.2.2.2 Low affordability and inaccessibility of cardiac surgeries in developing countries 49
5.2.3 OPPORTUNITIES 49
5.2.3.1 Growth potential of emerging economies 49
5.2.3.2 Increasing number of product approvals 50
TABLE 2 RECENT APPROVALS OF VARIOUS TYPES OF INTERVENTIONAL CARDIOLOGY DEVICES, 2018–2020 50
5.2.4 CHALLENGES 50
5.2.4.1 Stringent regulatory requirements delaying the approval of cardiac devices 50
5.2.4.2 Product failures and recalls 51
5.3 COVID-19 IMPACT ON THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET 51
5.4 PRICING ANALYSIS 52
TABLE 3 INTERVENTIONAL CARDIOLOGY DEVICES, AVERAGE SELLING PRICES (USD) 52
5.5 VALUE CHAIN ANALYSIS 52
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 52
5.6 SUPPLY CHAIN ANALYSIS 53
FIGURE 22 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES 54
5.7 ECOSYSTEM ANALYSIS 54
5.8 TECHNOLOGY ANALYSIS 55
5.9 REGULATORY LANDSCAPE 55
5.10 PESTLE ANALYSIS 57
6 ANGIOPLASTY STENTS MARKET, BY TYPE 58
6.1 INTRODUCTION 59
TABLE 4 ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 59
6.1.1 DRUG-ELUTING STENTS 59
6.1.1.1 Drug-eluting stents hold the largest share of the angioplasty stents market 59
TABLE 5 DRUG-ELUTING STENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 60
TABLE 6 DRUG-ELUTING STENTS MARKET, BY REGION,
2018–2025 (THOUSAND UNITS) 60
6.1.2 BARE-METAL STENTS 60
6.1.2.1 Increasing use of drug-eluting stents has limited the growth of the bare-metal stents market 60
TABLE 7 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 8 BARE-METAL STENTS MARKET, BY REGION, 2018–2025 (THOUSAND UNITS) 61
6.1.3 BIOABSORBABLE STENTS 61
6.1.3.1 Bioabsorbable stents ensure the complete healing of the arteries—a key factor driving market growth 61
TABLE 9 BIOABSORBABLE STENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 62
TABLE 10 BIOABSORBABLE STENTS MARKET, BY REGION,
2018–2025 (THOUSAND UNITS) 62
7 STRUCTURAL HEART DEVICES MARKET, BY TYPE 63
7.1 INTRODUCTION 64
TABLE 11 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 64
7.1.1 AORTIC VALVE THERAPY DEVICES 64
7.1.1.1 Increasing prevalence of aortic valve stenosis to support the market growth 64
TABLE 12 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 64
TABLE 13 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION,
2018–2025 (THOUSAND UNITS) 65
7.1.2 OTHER THERAPY DEVICES 65
TABLE 14 OTHER THERAPY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 65
8 CATHETERS MARKET, BY TYPE 66
8.1 INTRODUCTION 67
TABLE 15 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 67
8.1.1 ANGIOGRAPHY CATHETERS 67
8.1.1.1 Angiography catheters hold the largest share of the catheters market during the forecast period 67
TABLE 16 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2018–2025 (USD MILLION) 67
8.1.2 GUIDING CATHETERS 68
8.1.2.1 Guiding catheters to account for the second-largest share of the catheters market during the forecast period 68
TABLE 17 GUIDING CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 68
8.1.3 IVUS/OCT CATHETERS 68
8.1.3.1 IVUS/OCT catheters to register the highest growth rate during the forecast period 68
TABLE 18 IVUS/OCT CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 69
9 ANGIOPLASTY BALLOONS MARKET, BY TYPE 70
9.1 INTRODUCTION 71
TABLE 19 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION) 71
9.1.1 OLD/NORMAL BALLOONS 71
9.1.1.1 Low treatment costs associated with this technique to drive
the growth of the old/normal balloons market 71
TABLE 20 OLD/NORMAL BALLOONS MARKET, BY REGION, 2018–2025 (USD MILLION) 71
9.1.2 DRUG-ELUTING BALLOONS 72
9.1.2.1 Rising number of regulatory approvals for drug-eluting balloons to drive market growth during the forecast period 72
TABLE 21 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2018–2025 (USD MILLION) 72
9.1.3 CUTTING/SCORING BALLOONS 72
9.1.3.1 Use of cutting balloon-aided procedures is very limited since medication is the primary treatment for atherosclerosis 72
TABLE 22 CUTTING/SCORING BALLOONS MARKET, BY REGION,
2018–2025 (USD MILLION) 73
10 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 74
10.1 INTRODUCTION 75
TABLE 23 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 75
10.1.1 THROMBECTOMY DEVICES 75
10.1.1.1 Thrombectomy devices segment dominates the plaque modification devices market 75
TABLE 24 THROMBECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 75
10.1.2 ATHERECTOMY DEVICES 76
10.1.2.1 Growing use of lipid-modifying drugs for the treatment of atherosclerosis instead of atherectomy devices to limit market growth 76
TABLE 25 ATHERECTOMY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 76
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 77
11.1 INTRODUCTION 78
TABLE 26 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 78
11.1.1 EMBOLIC PROTECTION DEVICES 78
11.1.1.1 Embolic protection devices to dominate the hemodynamic flow alteration devices market during the forecast period 78
TABLE 27 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 78
11.1.2 CHRONIC TOTAL OCCLUSION DEVICES 79
11.1.2.1 CTO devices market has witnessed tremendous innovations, thereby expanding the options available for physicians 79
TABLE 28 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 79
12 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE 80
12.1 INTRODUCTION 81
TABLE 29 OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 81
12.1.1 GUIDEWIRES 81
TABLE 30 GUIDEWIRES MARKET, BY REGION, 2018–2025 (USD MILLION) 81
12.1.2 VASCULAR CLOSURE DEVICES 82
TABLE 31 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 82
12.1.3 INTRODUCER SHEATHS 82
TABLE 32 INTRODUCER SHEATHS MARKET, BY REGION, 2018–2025 (USD MILLION) 82
12.1.4 BALLOON INFLATION DEVICES 83
TABLE 33 BALLOON INFLATION DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 83
12.1.5 HEMOSTASIS HEART VALVES 83
TABLE 34 HEMOSTASIS HEART VALVES MARKET, BY REGION,
2018–2025 (USD MILLION) 83
13 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION 84
13.1 INTRODUCTION 85
TABLE 35 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 85
13.2 NORTH AMERICA 86
FIGURE 23 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT 86
TABLE 36 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 87
TABLE 37 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 87
TABLE 38 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 87
TABLE 39 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 88
TABLE 40 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 88
TABLE 41 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 88
TABLE 42 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 43 NORTH AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 89
13.2.1 US 89
13.2.1.1 Availability of reimbursements for interventional cardiology procedures to support the market growth 89
TABLE 44 REIMBURSEMENTS FOR INTERVENTIONAL CARDIOLOGY PROCEDURES, 2020 90
TABLE 45 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 90
TABLE 46 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 90
TABLE 47 US: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 91
TABLE 48 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION) 91
TABLE 49 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 91
TABLE 50 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 92
TABLE 51 US: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
13.2.2 CANADA 92
13.2.2.1 Rising incidence of target diseases to support the market growth 92
TABLE 52 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 93
TABLE 53 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 93
TABLE 54 CANADA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 55 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 94
TABLE 56 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 94
TABLE 57 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 94
TABLE 58 CANADA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 95
13.3 EUROPE 95
TABLE 59 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 60 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 96
TABLE 61 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 96
TABLE 62 EUROPE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 97
TABLE 63 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 97
TABLE 64 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 97
TABLE 65 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 66 EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
13.3.1 GERMANY 98
13.3.1.1 Germany holds the largest share of the European interventional cardiology devices market 98
TABLE 67 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 99
TABLE 68 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 99
TABLE 69 GERMANY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 99
TABLE 70 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 71 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 100
TABLE 72 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 100
TABLE 73 GERMANY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 101
13.3.2 FRANCE 101
13.3.2.1 Favorable government initiatives in France to support the growth of the interventional cardiology devices market in the country 101
TABLE 74 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 102
TABLE 75 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 102
TABLE 76 FRANCE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 102
TABLE 77 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 103
TABLE 78 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 103
TABLE 79 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 80 FRANCE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 104
13.3.3 UK 104
13.3.3.1 High burden of target diseases to drive the market in the country 104
TABLE 81 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 104
TABLE 82 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
TABLE 83 UK: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 84 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2018–2025 (USD MILLION) 105
TABLE 85 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 105
TABLE 86 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 87 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 106
13.3.4 SPAIN 106
13.3.4.1 Growing geriatric population to increase the demand for interventional cardiology devices in the country 106
TABLE 88 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 107
TABLE 89 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 90 SPAIN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 107
TABLE 91 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 107
TABLE 92 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 108
TABLE 93 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 108
TABLE 94 SPAIN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 108
13.3.5 ITALY 109
13.3.5.1 Rising levels of obesity to increase the demand for interventional cardiology devices in the country 109
TABLE 95 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 96 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
TABLE 97 ITALY: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 98 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 99 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 100 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 101 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 111
13.3.6 REST OF EUROPE 111
TABLE 102 ROE: HEALTH EXPENDITURE (% OF GDP), 2010 VS. 2017 111
TABLE 103 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 104 ROE: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 105 ROE: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 106 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 107 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 108 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
TABLE 109 ROE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 113
13.4 ASIA PACIFIC 114
FIGURE 24 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT 114
TABLE 110 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 115
TABLE 111 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 112 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 113 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 116
TABLE 114 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 115 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 116 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 117 ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 117
13.4.1 JAPAN 117
13.4.1.1 Japan dominates the Asia Pacific interventional cardiology devices market 117
TABLE 118 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 119 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 120 JAPAN: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 121 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 122 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 123 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 124 JAPAN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 120
13.4.2 CHINA 120
13.4.2.1 Highest tobacco consumption in the world—a major factor driving market growth in China 120
TABLE 125 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 120
TABLE 126 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 127 CHINA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 128 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 129 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 130 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 131 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
13.4.3 INDIA 122
13.4.3.1 Increasing target patient population to drive the market in the country 122
TABLE 132 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 133 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 134 INDIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 135 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 136 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 137 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 138 INDIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 125
13.4.4 AUSTRALIA 125
13.4.4.1 Increasing prevalence of heart diseases to support the market growth 125
TABLE 139 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 140 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 141 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 142 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 143 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 144 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 145 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 127
13.4.5 REST OF ASIA PACIFIC 127
TABLE 146 ROAPAC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 147 ROAPAC: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 148 ROAPAC: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 149 ROAPAC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 150 ROAPAC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 129
TABLE 151 ROAPAC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 152 ROAPAC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 129
13.5 REST OF THE WORLD 130
TABLE 153 ROW: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 130
TABLE 154 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 130
TABLE 155 ROW: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 156 ROW: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 131
TABLE 157 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 158 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 159 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 160 ROW: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 132
13.5.1 LATIN AMERICA 132
13.5.1.1 Latin America dominates the RoW interventional cardiology devices market 132
TABLE 161 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 132
TABLE 162 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 163 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 164 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 165 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 166 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 134
TABLE 167 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION) 134
13.5.2 MIDDLE EAST & AFRICA 135
13.5.2.1 Increasing prevalence of diabetes to support market growth in the Middle East & Africa 135
TABLE 168 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 135
TABLE 169 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 170 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 171 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 172 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 173 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
TABLE 174 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 137
14 COMPETITIVE LANDSCAPE 138
14.1 OVERVIEW 138
FIGURE 25 KEY DEVELOPMENTS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET, JANUARY 2017–NOVEMBER 2020 138
FIGURE 26 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO NOVEMBER 2020 139
14.2 COMPETITIVE SCENARIO 140
14.2.1 AGREEMENTS & PARTNERSHIPS 140
TABLE 175 KEY AGREEMENTS & PARTNERSHIPS 140
14.2.2 PRODUCT LAUNCHES & APPROVALS 140
TABLE 176 KEY PRODUCT LAUNCHES & APPROVALS 140
14.2.3 EXPANSIONS 141
TABLE 177 KEY EXPANSIONS 141
14.2.4 ACQUISITIONS 141
TABLE 178 KEY ACQUISITIONS 141
14.2.5 OTHER DEVELOPMENTS 142
TABLE 179 OTHER DEVELOPMENTS 142
14.3 MARKET SHARE ANALYSIS, 2019 142
FIGURE 27 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE ANALYSIS, 2019 142
14.4 COMPANY EVALUATION MATRIX 143
14.4.1 STARS 143
14.4.2 EMERGING LEADERS 143
14.4.3 PERVASIVE PLAYERS 144
14.4.4 PARTICIPANTS 144
FIGURE 28 VENDOR DIVE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET 144
14.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS/SMES) 145
14.5.1 PROGRESSIVE COMPANIES 145
14.5.2 STARTING BLOCKS 145
14.5.3 RESPONSIVE COMPANIES 145
14.5.4 DYNAMIC COMPANIES 145
FIGURE 29 VENDOR DIVE MATRIX FOR START-UPS: INTERVENTIONAL CARDIOLOGY DEVICES MARKET 146
15 COMPANY PROFILES 147
(Business overview, Products offered, Recent developments, MNM view)*
15.1 BOSTON SCIENTIFIC CORPORATION 147
FIGURE 30 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019) 147
15.2 MEDTRONIC PLC 150
FIGURE 31 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 150
15.3 ABBOTT LABORATORIES 153
FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 153
15.4 EDWARDS LIFESCIENCES CORPORATION 156
FIGURE 33 EDWARD LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2019) 156
15.5 TERUMO CORPORATION 158
FIGURE 34 TERUMO CORPORATION: COMPANY SNAPSHOT (2019) 158
15.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH, INC.) 161
FIGURE 35 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2019) 161
15.7 B. BRAUN MELSUNGEN AG 163
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019) 163
15.8 KONINKLIJKE PHILIPS N.V. 165
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 165
15.9 IVASCULAR S.L.U. 167
15.10 BIOSENSORS INTERNATIONAL 168
15.11 BIOTRONIK SE & CO. KG 169
15.12 PENUMBRA, INC. 171
FIGURE 38 PENUMBRA, INC: COMPANY SNAPSHOT (2019) 171
15.13 AMG INTERNATIONAL (A SUBSIDIARY OF Q3 MEDICAL) 172
15.14 ENDOCOR GMBH 173
15.15 INSITU TECHNOLOGIES, INC. 174
15.16 MERIL LIFE SCIENCES PVT. LTD. 175
15.17 ALVIMEDICA 177
15.18 CARDIONOVUM GMBH 179
15.19 SMT 180
15.20 MEDINOL LTD. 182
15.21 WELLINQ 183
15.22 SCITECH 184
15.23 COMED B.V. (A SUBSIDIARY OF LEPU MEDICAL TECHNOLOGY HOLDING) 185
15.24 BALTON SP. Z O.O 186
15.25 RONTIS 187
15.26 STENTYS SA 188
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
16 APPENDIX 189
16.1 INSIGHTS FROM INDUSTRY EXPERTS 189
16.2 DISCUSSION GUIDE 190
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 193
16.4 AVAILABLE CUSTOMIZATIONS 195
16.5 RELATED REPORTS 195
16.6 AUTHOR DETAILS 196



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のインターベンショナル心臓病装置市場(~2025年):種類別(ステント、構造的心臓、カテーテル、プラーク修正(アテレクトミー)、血行動態変化(塞栓保護、完全閉塞)、ガイドワイヤー、イントロデューサーシース、IVUS)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆